Mandibular Advancement Devices for Reflux in Obstructive Sleep Apnea
Launched by TUIUTI UNIVERSITY OF PARANÁ · Jun 25, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special mouthpiece, called a mandibular advancement device, can help reduce nighttime acid reflux in adults who have obstructive sleep apnea (a condition where breathing stops and starts during sleep). The device works by gently moving the lower jaw forward while you sleep. Researchers want to see if this device can not only lower acid reflux episodes at night but also improve sleep quality and overall daily well-being. They will compare this device to another similar mouthpiece that does not move the jaw forward to find out which works better.
Adults between 18 and 65 years old who have been diagnosed with obstructive sleep apnea and experience nighttime acid reflux may be eligible to join. Participants should not currently be using CPAP machines (a common treatment for sleep apnea) and need to have enough natural teeth to wear the mouthpieces comfortably. If you join, you will wear the assigned mouthpiece every night for six months, visit the clinic for regular check-ups and adjustments, and complete short questionnaires about your reflux symptoms, sleep, eating, and quality of life. The study will also measure saliva acidity and take X-rays before and after treatment. This research aims to offer a new option for people who find CPAP therapy hard to tolerate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 to 65 years
- • Clinical diagnosis of obstructive sleep apnea (OSA) confirmed by polysomnography type I
- • Presence of nocturnal gastroesophageal reflux symptoms
- • Not currently using CPAP therapy
- • Dentate individuals able to wear oral devices
- • Able and willing to comply with the study protocol
- • Provided written informed consent
- Exclusion Criteria:
- • Severe OSA (Apnea-Hypopnea Index \> 30)
- • Current or recent use of proton pump inhibitors or other anti-reflux medications
- • Neurological or neuromuscular disorders
- • Use of removable dental prostheses (partial or total)
- • Prior surgeries for apnea or reflux
- • Known allergy or intolerance to dental acrylic materials
- • Inability to attend follow-up visits or complete questionnaires
About Tuiuti University Of Paraná
Tuiuti University of Paraná is a distinguished academic institution located in Brazil, recognized for its commitment to advancing research and education in the health sciences. With a focus on fostering innovation and excellence, the university engages in clinical trials that aim to enhance medical knowledge and improve patient outcomes. By collaborating with a network of healthcare professionals and researchers, Tuiuti University of Paraná strives to contribute to the development of effective therapeutic solutions and promote evidence-based practices in clinical settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Curitiba, , Brazil
Patients applied
Trial Officials
José Stechman-Neto, PhD, DDS
Study Director
Universidade Tuiuti do Paraná
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported